Japan Looks To Update National Biotechnology Strategy
This article was originally published in PharmAsia News
Executive Summary
The Japanese government has set up a team to update its 2002 biotechnology strategic outline. The team will discuss topics such as promoting research and development, early commercialization of new technology and raising public awareness. Regenerative medicine and medical devices are also included in the discussions. The team plans to release a midterm report in June. Led by Tasuku Honjo of the Council for Science and Technology, the team consists of researchers and industrial representatives, including Hatsuo Aoki, president of the Japan Pharmaceutical Manufacturers Association. At the first meeting, Minister of State for Science, Technology and Innovation Policy, Fumio Kishida, commented that an industry-government-academia alliance is vital for the advancement of Japan's biotechnology policy. (Click here for more-J apanese language